Corrigendum to "Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer" [Biochem. Biophys. Res. Commun. 680 (2023) 161-170].
作者信息
Chiang Chen-Wei, Lin Yun-Shih, Chang Fu-Ling, Lin Tsai-Yu, Tsai Keng-Chang, HuangFu Wei-Chun, Lee Yu-Ching
机构信息
Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.
Department of Psychiatry, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.
出版信息
Biochem Biophys Res Commun. 2023 Dec 17;686:149085. doi: 10.1016/j.bbrc.2023.10.017. Epub 2023 Oct 13.
PMID:37839952
Abstract
摘要
相似文献
1
Corrigendum to "Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer" [Biochem. Biophys. Res. Commun. 680 (2023) 161-170].《单链片段抗体作为胃癌治疗药物破坏EphA4功能》的勘误[《生物化学与生物物理研究通讯》680 (2023) 161 - 170]
Biochem Biophys Res Commun. 2023 Dec 17;686:149085. doi: 10.1016/j.bbrc.2023.10.017. Epub 2023 Oct 13.
2
Corrigendum to "Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity" [Biochem. Biophys. Res. Commun. 496 (1) (2018 Jan 29) 76-82].《“Netrin-1通过调节YAP活性促进胃癌转移”的勘误》[《生物化学与生物物理研究通讯》496(1)(2018年1月29日)76 - 82]
Biochem Biophys Res Commun. 2018 Mar 25;498(1):262. doi: 10.1016/j.bbrc.2018.02.197. Epub 2018 Mar 3.
3
Corrigendum to "Toosendanin induces caspase-dependent apoptosis through the p38 MAPK pathway in human gastric cancer cells" [Biochem. Biophys. Res. Commun. 505(1) (2018) 261-266].《川楝素通过p38丝裂原活化蛋白激酶途径诱导人胃癌细胞发生半胱天冬酶依赖性凋亡》的勘误[《生物化学与生物物理研究通讯》505(1)(2018)261 - 266]
Biochem Biophys Res Commun. 2020 Nov 12;532(3):496. doi: 10.1016/j.bbrc.2020.09.012. Epub 2020 Sep 28.
4
Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer.单链抗体片段阻断 EphA4 功能可作为治疗胃癌的药物。
Biochem Biophys Res Commun. 2023 Nov 5;680:161-170. doi: 10.1016/j.bbrc.2023.09.025. Epub 2023 Sep 15.
5
Corrigendum to "Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells" [Biochem. Biophys. Res. Commun. 480 (2016) 461-467].
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1517. doi: 10.1016/j.bbrc.2016.11.116. Epub 2016 Nov 26.
6
Corrigendum to "Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphomaˮ [Biochem. Biophys. Res. Commun. 485 (1) 2017 144-151].《针对成人T细胞白血病/淋巴瘤的抗转铁蛋白受体1全人源IgG单克隆抗体的研发》勘误[《生物化学与生物物理研究通讯》485 (1) 2017 144 - 151]
Biochem Biophys Res Commun. 2020 Sep 17;530(2):486. doi: 10.1016/j.bbrc.2020.05.147. Epub 2020 Jun 16.
7
Corrigendum to "A highly efficient method for extracting peptides from a single mouse hypothalamus" [Biochem. Biophys. Res. Commun. 548 (2021) 155-160].《从单个小鼠下丘脑提取肽的高效方法》的勘误[《生物化学与生物物理研究通讯》548 (2021) 155 - 160]
Biochem Biophys Res Commun. 2022 Feb 5;591:145. doi: 10.1016/j.bbrc.2021.03.008. Epub 2021 Jun 23.
8
Corrigendum to "TTK inhibitor promotes radiosensitivity of liver cancer cells through p21" [Biochem. Biophys. Res. Commun. 550(2021) 84-91].《“TTK抑制剂通过p21促进肝癌细胞放射敏感性”的勘误》[《生物化学与生物物理研究通讯》550(2021) 84 - 91]
Biochem Biophys Res Commun. 2021 May 28;555:214. doi: 10.1016/j.bbrc.2021.03.164. Epub 2021 Apr 8.
9
Corrigendum to "Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer." [Biochem. Biophys. Res. Commun. 2014 oct 24, 453(3), 545-51].《“假基因CYP4Z2P 3'非翻译区促进乳腺癌血管生成”的勘误》[《生物化学与生物物理研究通讯》2014年10月24日，453(3)，545 - 51]
Biochem Biophys Res Commun. 2020 Jan 8;521(2):546-547. doi: 10.1016/j.bbrc.2019.10.131. Epub 2019 Oct 28.
10
Corrigendum to "CircNUP214 sponges miR-145 to promote the expression of ZEB2 in thyroid cancer cells" [Biochem Biophys Res Commun. 507 (1-4) (2018) 168-172].《“环状核孔蛋白214通过吸附miR-145促进甲状腺癌细胞中ZEB2的表达”的勘误》[《生物化学与生物物理研究通讯》507卷第1 - 4期（2018年）168 - 172页]
Biochem Biophys Res Commun. 2019 Mar 12;510(3):488. doi: 10.1016/j.bbrc.2019.01.044. Epub 2019 Feb 2.
Zotero 插件